Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients
Infectious Disease Clinical Pharmacology
The study will use an antibiotic named moxifloxacin in children. Moxifloxacin will be given in addition to the standard antibiotic therapy they are receiving. It will be one dose and blood samples will be collected after the dose to measure the amount of moxifloxacin in the body. Children between the ages of 3 months to 14 years who are currently receiving antibiotics an infection are being enrolled.
The study requires multiple office visits and follow-up at 1 year. It includes at no cost to you or your child:
• Lab Testing
• Physical Exam
• Study Medication
Compensation is provided for time and travel.
Contact Lee Howard at 501-364-6990 or at pager number 501-395-6700.
Ages 3 months to 14 years and currently receiving an antibiotic for infection Request Information for This Trial